Harrow, Inc. (HROW)

39.22 +0.62 (+1.59%) USD  |  NASDAQ  |  Mar 04, 16:00
39.80 +0.58 (+1.48%) Pre-Market: 08:24
More

Harrow Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Xeris Biopharma Holdings, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade